StockData

Adagio Medical vs AtriCure

ADGM and ATRC side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ADGM and ATRC compare

AtriCure is the larger company, worth 1907 times as much as Adagio Medical ($2.8B against $1.5M).

AtriCure scores higher on the StockData Score (12 against 2 for Adagio Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricADGMATRC
Size and price
Market cap$1.5M$2.8B
Share price$1.65$55.02
Change, 1 year110%67.2%
Change, 5 years−99.4%−22.5%
Beta (5Y)–0.47
Employees411,350
StockData Score
Total score212 (better)
Valuation score1 (better)0
Growth score04 (better)
Performance score13 (better)
Health score05 (better)
Dividend score00
Valuation
P/E–262×
P/S–4.9×
P/B0.1× (better)5.4×
EV/EBITDA–209×
P/FCF–52.7×
FCF yield−1203%1.9% (better)
Fair value–$5.54
Margin of safety–−893%
Growth
Revenue growth (TTM)–13.9%
Revenue growth, 5Y average–20.9%
Profitability
Gross margin–76.3%
Operating margin–2.3%
Net margin–1.9%
FCF margin–9.3%
Return on equity9.6% (better)2.2%
Return on invested capital−314%2.7% (better)
Financial health
Debt / equity–0.12
Net debt / EBITDA–−8.28
Interest coverage−5.8×2.3× (better)
Current ratio0.904.22 (better)
Altman Z-score−6.2911.02 (better)
Piotroski F-score–7
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions–104%
Held by insiders–4.0%
Insider net buying, 12 months$244K (better)−$4.4M
Short interest, % of float–10.0%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.